Drugs & Targets HanchorBio and WuXi Biologics form partnership to advance next-generation bi-and multi-functional fusion protein pipeline January 30, 2026Vol.52 No.04
Drugs & Targets ACR names University Hospital of Bern first international ARCH AI Site January 30, 2026Vol.52 No.04
Premarin’s 84-year hold on the market ends as FDA approves a generic versionTrade secret protections helped the hormone drug resist generic entry and outlast safety controversies—including link to cancer January 23, 2026Vol.52 No.03By Claire Marie Porter
Capitol Hill Spending bill passed by the House gives NIH $415M raise, NCI gets $128MLegislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched January 23, 2026Vol.52 No.03By Jacquelyn Cobb
Capitol Hill Fifth time’s a charm? Mikaela Naylon Give Kids a Chance Act is included in FY26 spending bill January 23, 2026Vol.52 No.03By Jacquelyn Cobb
Guest Editorial Blood Cancer United: A new name at the right moment January 23, 2026Vol.52 No.03By E. Anders Kolb
Cancer Policy ACA Marketplace enrollments down by 1.4 million, early data shows January 23, 2026Vol.52 No.03By Sara Willa Ernst
Cancer Policy Workforce shortages will threaten access to cancer care, President’s Cancer Panel says in a report January 23, 2026Vol.52 No.03
In Brief Monica Bertagnolli elected president of the National Academy of Medicine January 23, 2026Vol.52 No.03
